These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18613897)

  • 1. Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement.
    Lobo T; Morgan J; Bjorksten A; Nicholls K; Grigg L; Centra E; Becker G
    Intern Med J; 2008 Jun; 38(6):407-14. PubMed ID: 18613897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
    Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiopulmonary exercise capacity increases after interventional ASD-closure].
    Weber M; Neumann T; Rau M; Brandt R; Dill T; Maikowski C; Mitrovic V; Hamm C
    Z Kardiol; 2004 Mar; 93(3):209-15. PubMed ID: 15024588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients.
    Agostoni P; Emdin M; Corrà U; Veglia F; Magrì D; Tedesco CC; Berton E; Passino C; Bertella E; Re F; Mezzani A; Belardinelli R; Colombo C; La Gioia R; Vicenzi M; Giannoni A; Scrutinio D; Giannuzzi P; Tondo C; Di Lenarda A; Sinagra G; Piepoli MF; Guazzi M
    Eur Heart J; 2008 Oct; 29(19):2367-72. PubMed ID: 18682448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.
    Carvalho MR; Sato EI; Tebexreni AS; Heidecher RT; Schenkman S; Neto TL
    Arthritis Rheum; 2005 Dec; 53(6):838-44. PubMed ID: 16342102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.
    Carvalho VO; Ruiz MA; Bocchi EA; Carvalho VO; Guimarães GV
    Cardiol J; 2009; 16(5):426-31. PubMed ID: 19753521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M; Dickstein K; Vicenzi M; Arena R
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise capacity of a contemporary cohort of children with hypoplastic left heart syndrome after staged palliation.
    Möller P; Weitz M; Jensen KO; Dubowy KO; Furck AK; Scheewe J; Kramer HH; Uebing A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):980-5. PubMed ID: 19643621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of exercise training heart rate in patients on beta-blockers after myocardial infarction.
    Tabet JY; Meurin P; Ben Driss A; Thabut G; Weber H; Renaud N; Odjinkem N; Solal AC
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):538-43. PubMed ID: 16874142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease.
    Niedeggen A; Skobel E; Haager P; Lepper W; Mühler E; Franke A
    Cardiol Young; 2005 Aug; 15(4):385-90. PubMed ID: 16014186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rate-adaptive atrial pacing versus ventricular backup pacing on exercise capacity in patients with left ventricular dysfunction.
    Passman R; Banthia S; Galvez D; Sheldon T; Kadish A
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):1-6. PubMed ID: 19140906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome?
    Frigiola A; Tsang V; Bull C; Coats L; Khambadkone S; Derrick G; Mist B; Walker F; van Doorn C; Bonhoeffer P; Taylor AM
    Circulation; 2008 Sep; 118(14 Suppl):S182-90. PubMed ID: 18824753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary exercise testing in Fabry disease.
    Bierer G; Kamangar N; Balfe D; Wilcox WR; Mosenifar Z
    Respiration; 2005; 72(5):504-11. PubMed ID: 16210890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of heart rate during exercise for response to cardiac resynchronization therapy.
    Maass AH; Buck S; Nieuwland W; Brügemann J; van Veldhuisen DJ; Van Gelder IC
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):773-80. PubMed ID: 19207785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerobic capacity is associated with 100-day outcome after hepatic transplantation.
    Epstein SK; Freeman RB; Khayat A; Unterborn JN; Pratt DS; Kaplan MM
    Liver Transpl; 2004 Mar; 10(3):418-24. PubMed ID: 15004771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac performance during exercise in patients with Fabry's disease.
    Spinelli L; Nicolai E; Acampa W; Imbriaco M; Pisani A; Rao MA; Scopacasa F; Cianciaruso B; De Luca N; Cuocolo A
    Eur J Clin Invest; 2008 Dec; 38(12):910-7. PubMed ID: 19021715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.